T. Yachnin

Intravenous iron for the treatment of predialysis anemia.

D. Schwartz, D. Silverberg, A. Iaina, 1999, Kidney international. Supplement.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations.

I. Shapira, D. Schwartz, C. Kaplan, 2000, Journal of the American College of Cardiology.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

D. Schwartz, D. Silverberg, A. Iaina, 2001, Clinical nephrology.

The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization.

D. Schwartz, D. Silverberg, G. Keren, 2002, Clinical nephrology.

Low Nitric Oxide Production in Patients with Chronic Renal Failure

D. Silverberg, S. Cabili, A. Iaina, 1998, Nephron.

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

I. Shapira, D. Schwartz, D. Silverberg, 2001, Journal of the American College of Cardiology.

Aggressive Therapy of Congestive Heart Failure and Associated Chronic Renal Failure with Medications and Correction of Anemia Stops or Slows the Progression of Both Diseases

D. Schwartz, D. Silverberg, G. Keren, 2001, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The low‐dose (1 μg) adrenocorticotropin stimulation test in kidney and kidney–pancreas transplant patients: a potential guideline for steroid withdrawal

N. Stern, K. Tordjman, T. Yachnin, 2006, Clinical transplantation.

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.

D. Schwartz, D. Silverberg, G. Keren, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study.

I. Shapira, D. Schwartz, D. Silverberg, 2001, Journal of the American College of Cardiology.